1. Introduction {#sec1-foods-09-00269}
===============

*Hippophae rhamnoides* L. (commonly known as 'Sea buckthorn' and 'Vitamin tree') is a spiny deciduous shrub belonging to the Elaeagnaceae family. The fruit of *H. rhamnoides* is rich in vitamin C and its levels exceed those found in lemons and oranges \[[@B1-foods-09-00269]\]. The berries of *H. rhamnoides* are usually washed and pressed to create pomace and juice. In many countries, the powder from the aqueous extract of *H. rhamnoides* berries are consumed as a functional food. The berry of *H. rhamnoides* is used as food and medicine in Asia, specifically in Tibetan and Mongolian medicines, owing to its antibechic, antiviral, and antioxidant activities \[[@B2-foods-09-00269],[@B3-foods-09-00269]\]. Moreover, the berries are used to make fruit sauce, fruit powder, and fruit wine \[[@B4-foods-09-00269]\]. Previous biological studies of the *H. rhamnoides* extracts revealed their anti-platelet effect through the inhibition of thrombin-activated platelets to collagen or fibrinogen \[[@B5-foods-09-00269]\]. The phenolic and nonpolar lipid fractions of the *H. rhamnoides* extracts attenuate the essential pathogenic properties of *Staphylococcus aureus* and *Candida albicans*, and the mechanism of the effect was found to be due to a decrease in adhesion and biofilm formation on inert surfaces \[[@B6-foods-09-00269]\]. Previously, a study found that the pomace of *H. rhamnoides* exerts antioxidant activity \[[@B7-foods-09-00269]\]. Therefore, because of the health benefits of *H. rhamnoides*, its phytochemical constituents were investigated, and further demonstrated to include flavonoids, alkaloids, protocatechuic acid, and triterpenoid glycosides \[[@B8-foods-09-00269],[@B9-foods-09-00269],[@B10-foods-09-00269]\]. Among them, isorhamnetin 3,5,7,4-tetrahydroxy-3-methoxyflavon, isorhamnetin 3-*O*-*β*-D-glucopyranosil-(6-1)-*O*-*α*-1-rhamnopyranoside, and protocatechuic acid were found to have a regulatory effect on hepatic stellate cell activation and liver fibrogenesis by affecting changes in DNA expression and cell cycle arrest, and decreasing the release of cytokines \[[@B11-foods-09-00269]\].

As natural products are rich sources of anti-inflammatory agents \[[@B12-foods-09-00269],[@B13-foods-09-00269]\], evaluating their anti-inflammatory effects using laboratory models is important for drug discovery. Inflammation is a critical immune response to different factors, such as bacteria, chemicals, and viruses, that result in inflammation-mediated diseases, including inflammatory bowel disease, cancer, atherosclerosis, diabetes, and asthma \[[@B14-foods-09-00269]\]. Discovering the bioactive constituents present in natural products can thus serve as an approach to prevent and treat inflammation-mediated diseases. Numerous laboratory models are available for screening and assessing the anti-inflammatory agents derived from natural products \[[@B12-foods-09-00269]\]. Through in vitro and in vivo laboratory models, macrophages have been identified as the principal cell type in the innate immune system \[[@B15-foods-09-00269]\]. Lipopolysaccharides (LPS), which are known as an endotoxin of Gram-negative bacteria, have been widely used to study the inflammatory response in macrophages. This is because activated macrophages release NO as an indicator of pro-inflammatory reactions in response to LPS \[[@B16-foods-09-00269],[@B17-foods-09-00269]\]. During the above process, the nuclear factor kappa-B (NF-κB) proteins translocate to the nucleus from the cytoplasm and induce the transcription of pro-inflammatory mediators and cytokines \[[@B18-foods-09-00269]\]. Thus, the ability of NF-κB to modulate the expression of cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), interleukin 6 (IL-6), and tumor necrosis factor alpha (TNFα) allows us to assess the anti-inflammatory effect of natural products against inflammatory response.

As part of our ongoing research to discover the bioactive constituents in natural sources \[[@B19-foods-09-00269],[@B20-foods-09-00269],[@B21-foods-09-00269],[@B22-foods-09-00269]\], here we elucidated the bioactive compounds in the fruits of *H. rhamnoides*. Through a phytochemical analysis of the extract from *H. rhamnoides* fruits, we isolated and identified six compounds, including a citric acid derivative (**1**), a phenolic (**2**), two flavonoids (**3** and **4**), and two megastigmane compounds (**5** and **6**), through a comparison of their nuclear magnetic resonance (NMR) spectroscopic data to their reported values and the results of LC/MS analysis. In the present study, we sought to report the anti-inflammatory effect of the constituents of *H. rhamnoides* and elucidate the underlying molecular mechanism whereby the active compound **1** modulates the NF-κB p65 signaling pathway, which affects the LPS-induced inflammatory responses in RAW 264.7 mouse macrophages.

2. Materials and Methods {#sec2-foods-09-00269}
========================

2.1. General Experimental Procedures {#sec2dot1-foods-09-00269}
------------------------------------

Ultraviolet (UV) spectra were acquired on an Agilent 8453 UV-visible spectrophotometer (Agilent Technologies, Santa Clara, CA, USA). Experimental electronic circular dichroism (ECD) spectra in methanol (MeOH) were acquired in a quartz cuvette of 1 mm optical path length on a JASCO J-1500 spectropolarimeter (Tokyo, Japan). Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker AVANCE III HD 850 NMR spectrometer with a 5 mm TCI CryoProbe operated at 850 MHz (^1^H) and 212.5 MHz (^13^C) (Bruker, Karlsruhe, Germany). For the ^1^H and ^13^C NMR analyses, chemical shifts are expressed in ppm (δ). Medium-pressure liquid chromatography (MPLC) was conducted using Smart Flash AKROS (Yamazen, Osaka, Japan). Semi-preparative HPLC was carried out using a Shimadzu Prominence HPLC System with SPD-20A/20AV Series Prominence HPLC UV-VIS detectors (Shimadzu, Tokyo, Japan) and a Phenomenex Luna C18 column (250 × 10 mm, 5 μm; flow rate: 2 mL/min; Phenomenex, Torrance, CA, USA). LC/MS analysis was performed on an Agilent 1200 Series HPLC system equipped with a diode array detector, a 6130 Series ESI mass spectrometer, and an analytical Kinetex C18 100 Å column (100 × 2.1 mm, 5 μm; flow rate: 0.3 mL/min; Phenomenex). Silica gel 60 (230--400 mesh; Merck, Darmstadt, Germany) and RP-C~18~ silica gel (Merck, 230--400 mesh) were used for column chromatography. Sephadex LH-20 (Pharmacia, Uppsala, Sweden) was employed as the packing material for molecular sieve column chromatography. Merck precoated silica gel F~254~ plates and RP-C~18~ F~254s~ plates were used for thin-layer chromatography (TLC). Following TLC, spots were detected under UV light or by heating when sprayed with anisaldehyde-sulfuric acid.

2.2. Plant Material {#sec2dot2-foods-09-00269}
-------------------

The powder of *H. rhamnoides* fruits was purchased in October of 2018 from Korea Beauty and Healthcare Co., Ltd. Thereafter, the material was identified by one of the authors (K.H.K). A voucher specimen of the material (VT-2018) was deposited in the herbarium at the School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.

2.3. Extraction and Isolation {#sec2dot3-foods-09-00269}
-----------------------------

The aqueous extract powder (270 g) of *H. rhamnoides* fruits was suspended in distilled water (700 mL) prior to solvent partitioning with *n*-hexane, dichloromethane (CH~2~Cl~2~), ethyl acetate (EtOAc), and *n*-butanol (BuOH) to obtain four partitioned layers: hexane-soluble (2.7 g), methylene chloride (MC)-soluble (3.4 g), ethyl acetate (EA)-soluble (7.8 g), and BuOH-soluble (25.2 g) layers. The MC-soluble layer (3.4 g) was subjected to silica gel column chromatography (100 g, eluted with MC/MeOH (100:1 ⟶ 1:1); gradient solvent system, washed with 100% MeOH) to yield seven fractions (C1-C7). Fraction C4 (55.7 mg) was separated via MPLC on a Yamazen UNIVERSAL Premium silica column with MC/MeOH (100:0 ⟶ 1:1) to yield four subfractions (C41--C44). Subfraction C41 (46.4 mg) was separated on a Sep-pak C18 cartridge using a solvent system consisting of 90% MeOH to yield three subfractions (C411--C413). Subfraction C411 (17.4 mg) was subsequently purified by semi-preparative HPLC (35% MeOH) on a Phenomenex Luna C18 column to yield compound **5** (*t*~R~ 36.5 min, 0.5 mg). Fraction C5 (74.5 mg) was purified by semi-preparative HPLC (39% MeOH) on a Phenomenex Luna C18 column to yield compound **6** (*t*~R~ 23.0 min, 1.5 mg). The EA-soluble layer (7.8 g) was chromatographed by silica gel column chromatography (200 g, eluted with MC/MeOH (20:1 ⟶ 1:1); gradient solvent system, washed with 100% MeOH) to yield seven fractions (E1-E7). Fraction E3 (751.1 mg) was separated on a Sephadex LH-20 column using a solvent system of 100% MeOH to yield five subfractions (E31--E35). Subfraction E35 (15.7 mg) was purified by semi-preparative HPLC (19% acetonitrile) on a Phenomenex Luna C18 column to yield compound **2** (*t*~R~ 34.8 min, 1.0 mg). Fraction E4 (1.37 g) was separated on a Sephadex LH-20 column using a solvent system of 100% MeOH to yield three subfractions (E41-E43). Subfraction E42 (1.24 g) was subjected to silica gel column chromatography (100 g, eluted with MC/MeOH (20:1 ⟶ 1:1); gradient solvent system, washed with 80% MeOH) to yield six subfractions (E421--E426). Subfraction E422 (391.3 mg) was separated by reversed-phase preparative HPLC on an Agilent Eclipse C18 column with a gradient solvent system of MeOH/H~2~O (10%--70%--100%) to yield five subfractions (E4221--E4225). Subfraction E4223 was purified by semi-preparative HPLC (20% MeOH) on a Phenomenex Luna C18 column to yield subfraction E42236. Subfraction E42236 (23.0 mg) was re-purified by semi-preparative HPLC (10% MeOH) on a Phenomenex Luna C18 column to yield compound **1** (*t*~R~ 37.5 min, 6.0 mg). Subfraction E43 (55.3 mg) was separated by semi-preparative HPLC (15% MeOH) to yield six subfractions (E431--E436). Subfraction E436 was purified by semi-preparative HPLC (38% MeOH) on a Phenomenex Luna C18 column to yield compounds **3** (*t*~R~ 56.6 min, 0.6 mg) and **4** (*t*~R~ 58.5 min, 0.9 mg).

2.4. RAW 264.7 Cell Culture {#sec2dot4-foods-09-00269}
---------------------------

The mouse macrophage cell line, RAW 264.7 (American Type Culture Collection, Rockville, MD, USA), was cultured in Dulbecco's modified Eagle's medium (Cellgro, VA, USA) containing 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (Invitrogen Co., NY, USA) at 37 °C in an atmosphere of 5% CO~2~.

2.5. Measurement of RAW 264.7 Cell Viability {#sec2dot5-foods-09-00269}
--------------------------------------------

RAW 264.7 cell viability was determined using an Ez-Cytox cell viability detection kit (Daeil Lab Service Co., Seoul, Korea). Cells were plated in 96-well plates at a density of 3 × 10^4^ cells/well and incubated for 24 h at 37 °C. Cells were exposed to compounds at concentrations of 5, 10, 25, 50, and 100 μM for 1 h at 37 °C. Thereafter, they were incubated with vehicle (medium containing 0.5% DMSO) for 24 h at 37 °C. After that, they were incubated with the Ez-Cytox solution for 40 min at 37 °C. Absorbance was determined at 450 nm using a PowerWave XS microplate reader (Bio-Tek Instruments, Winooski, VT, USA).

2.6. Measurement of NO Production in RAW 264.7 Cells {#sec2dot6-foods-09-00269}
----------------------------------------------------

RAW 264.7 cells were plated in 96-well plates at a density of 3 × 10^4^ cells/well for a 24 h incubation at 37 °C. Cells were either exposed to the compounds or *N*^G^-methyl-L-arginine acetate salt (L-NMMA) at concentrations of 5, 10, 25, 50, and 100 μM for 1 h at 37 °C. Thereafter, they were incubated with 1 μg/mL LPS for 24 h at 37 °C. The supernatant was mixed with an equal volume of Griess reagent containing 0.2% naphthylethylenediamine dihydrochloride (Sigma-Aldrich, St. Louis, MO, USA) and 2% sulfanilamide (Sigma-Aldrich) in 5% phosphoric acid (Sigma-Aldrich) and incubated for 40 min at 37 °C. The absorbance was then measured at 540 nm using a PowerWave XS microplate reader.

2.7. Western Blot Analysis {#sec2dot7-foods-09-00269}
--------------------------

RAW 264.7 cells were plated in 6-well plates at a density of 2 × 10^5^ cells/well and incubated for 24 h at 37 °C. Cells were exposed to 50 and 100 μM of compound **1** for 1 h at 37 °C prior to incubation with 1 μg/mL LPS for 24 h at 37 °C. Whole-cell extracts were then prepared using radio immunoprecipitation assay buffer (RIPA buffer; Cell Signaling Technology, Inc., Beverly, MA, USA) containing 1× ethylenediaminetetraacetic acid (EDTA)-free protease inhibitor cocktail and 1 mM phenylmethylsulfonyl fluoride (PMSF), according to the manufacturer's instructions. Protein concentration of the whole-cell extracts was determined with a bicinchoninic acid (BCA) protein assay kit. Proteins (20 μg/lane) were subjected to 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS--PAGE) for 90 min at 110 V, transferred to a polyvinylidene fluoride (PVDF) membrane, and analyzed with epitope-specific primary antibodies to phospho-IκB kinase (IKK)α/β, IKKα (IκB kinase alpha), IKKβ (IκB kinase beta), I-κBα (inhibitor of kappa B alpha), phospho-I-κBα, phospho-NF-κB p65, NF-κB p65, and iNOS, followed by cyclooxygenase-2 (COX-2), glyceraldehyde 3-phosphate dehydrogenase (GAPDH), and horseradish peroxidase (HRP)-conjugated anti-rabbit antibodies (Cell Signaling, MA, USA). The bound antibodies were then visualized with ECL Advance Western Blotting Detection Reagents (GE Healthcare, Cambridge, United Kingdom) and a FUSION Solo Chemiluminescence System (PEQLAB Biotechnologie GmbH, Erlangen, Germany). The optical densities of the immunoreactive bands were obtained using ImageJ software (Version 1.51J; National Institutes of Health, Bethesda, MD, USA) and normalized with those of the control. Data represented by fold-increases were compared to the control. The GAPDH was used for loading control.

2.8. Determination of IL-6 and TNF-α Production {#sec2dot8-foods-09-00269}
-----------------------------------------------

RAW 264.7 cells were plated in 24-well plates at a density of 4 × 10^5^ cells/well and incubated for 24 h at 37 °C. Cells were then exposed to compound **1** at concentrations of 50 and 100 μM for 1 h at 37 °C prior to incubation with 1 μg/mL LPS for 24 h at 37 °C. To determine IL-6 and tumor necrosis factor alpha (TNF-α) production, the supernatant was obtained and assayed to quantify the levels of these cytokines using an IL-6 sandwich enzyme-linked immunosorbent assay (ELISA) kit (BD Biosciences, CA, USA) and a TNF-α ELISA kit (eBiosciences, CA, USA), according to the manufacturer's instructions.

2.9. Statistical Analysis {#sec2dot9-foods-09-00269}
-------------------------

At least three independent determinations were carried out for each experiment. All data are presented as average value and standard deviation (SD). Statistical significance was determined using one-way analysis of variance (ANOVA), and multiple comparisons were carried out with a Bonferroni correction. A *p*-value less than 0.05 indicated statistical significance. All statistical analyses were performed using SPSS Statistics version 19.0 (SPSS Inc., Chicago, IL, USA).

3. Results and Discussion {#sec3-foods-09-00269}
=========================

3.1. Isolation and Identification of Compounds {#sec3dot1-foods-09-00269}
----------------------------------------------

The aqueous extract powder of *H. rhamnoides* fruits was first suspended in distilled water, and then subjected to solvent-partitioning with *n*-hexane, CH~2~Cl~2~, ethyl acetate, and *n*-BuOH to obtain each solvent fraction. Phytochemical analysis of the CH~2~Cl~2~-soluble and ethyl acetate-soluble fractions was performed using repeated column chromatography, HPLC, and LC/MS. Through chemical analysis, six compounds (**1**--**6**), including a citric acid derivative (**1**), a phenolic (**2**), two flavonoids (**3** and **4**), and two megastigmane compounds (**5** and **6**) ([Figure 1](#foods-09-00269-f001){ref-type="fig"}) were isolated; compounds **1**-**4** were isolated from the ethyl acetate-soluble fraction whereas compounds **5**-**6** were isolated from the CH~2~Cl~2~-soluble fraction. By comparing the NMR spectroscopic data of the compounds to their reported values and the LC/MS results, we identified that the compounds were 1,5-dimethyl citrate (**1**) \[[@B23-foods-09-00269]\], 5-methoxysalicylic acid (**2**) \[[@B24-foods-09-00269]\], syringetin-3-*O*-glucoside (**3**) \[[@B25-foods-09-00269]\], isorhamnetin-3-*O*-glucoside (**4**) \[[@B9-foods-09-00269]\], (+)-dehydrovomifoliol (**5**) \[[@B26-foods-09-00269]\], and (+)-vomifoliol (**6**) \[[@B27-foods-09-00269]\]. In particular, the absolute configurations for compounds **5** and **6** were established by their positive specific rotation values and comparison of their NMR spectroscopic data with those reported earlier and electronic circular dichroism (ECD) data ([Figure S1](#app1-foods-09-00269){ref-type="app"}) \[[@B26-foods-09-00269],[@B27-foods-09-00269]\].

3.2. Effects of Compounds **1**--**6** on Cell Viability {#sec3dot2-foods-09-00269}
--------------------------------------------------------

Prior to evaluating the effect of the compounds on NO production, we determined their cytotoxicity in RAW 264.7 mouse macrophages using an Ez-Cytox cell viability assay. As a result, the compounds were considered to be cytotoxic when the cell viability in the compound-treated group was less than 80% of that in the untreated group. At all tested concentrations, all concentrations of compounds **1**--**6** had no cytotoxicity on RAW 264.7 mouse macrophages ([Figure 2](#foods-09-00269-f002){ref-type="fig"}). Therefore, all concentrations were employed for the subsequent experiments.

3.3. Effects of Compounds **1**--**6** on NO Production {#sec3dot3-foods-09-00269}
-------------------------------------------------------

The production of NO in LPS-induced RAW 264.7 macrophages has been used as an indicator to evaluate the anti-inflammatory effects of natural products. In the present study, we evaluated the effect of compounds **1--6** on LPS-induced NO production in RAW 264.7 cells. In this assay, L-NMMA, a nitric oxide synthase inhibitor, was used as the positive control. As shown in [Figure 3](#foods-09-00269-f003){ref-type="fig"}, exposure to 1 μg/mL LPS induced a significant increase in NO production; however, this was suppressed by pretreatment with compounds **1--6**, which had 50% inhibitory concentration (IC~50~) values of 39.76 ± 0.16 μM, 79.39 ± 0.29 μM, 86.33 ± 0.54 μM, 87.01 ± 0.30 μM, 74.71 ± 0.24 μM, and 76.12 ± 0.14 μM, respectively. Although the IC~50~ values of most compounds were slightly weaker than that of L-NMMA (IC~50~, 28.48 ± 0.05 μM), compound **1** displayed a similar IC~50~ value, which indicates that it might inhibit the increase of LPS-induced NO production in RAW 264.7 macrophages. This finding suggests that the inflammatory responses induced by extracellular stimuli might be suppressed via treatment with compound **1**. Thus, we proceeded to investigate the potential benefit of compound **1** as an NO production inhibitor by carrying out a mechanism study.

3.4. Compound **1** Downregulated IKKα/β, I-κBα, and NF-κB p65 in LPS-Stimulated RAW 264.7 Mouse Macrophages {#sec3dot4-foods-09-00269}
------------------------------------------------------------------------------------------------------------

When macrophages are stimulated with LPS, IKKα/β is phosphorylated, thereby leading to the subsequent phosphorylation and degradation of IκBα, which enables the nuclear translocation of NF-κB \[[@B28-foods-09-00269]\]. NF-κB p65 is a core mediator of the innate immune response that leads to the transcription of genes encoding pro-inflammatory mediators, such as iNOS and COX-2, and pro-inflammatory cytokines, such as TNF-α and IL-6 \[[@B29-foods-09-00269],[@B30-foods-09-00269]\]. Therefore, to confirm whether pre-treatment with compound **1** could suppress LPS-stimulated NO production through the NF-κB p65 signaling pathway, we determined the effect of compound **1** on the expression of IKKα/β, I-κBα, and NF-κB p65 in LPS-stimulated RAW 264.7 mouse macrophages. As shown in [Figure 4](#foods-09-00269-f004){ref-type="fig"}, exposure to 1 μg/mL LPS significantly upregulated IKKα/β, I-κBα, and NF-κB p65; however, pretreatment with 50 and 100 μM of compound **1** reversed these changes induced by LPS. Such findings indicate that compound **1** inhibits NO production by inhibiting the phosphorylation of IKKα/β, I-κBα, and NF-κB p65 in RAW 264.7 macrophages. On the basis of these results, it appears that the action site of compound **1** is upstream of the IKK site, thus modulating inflammatory mediator expression.

3.5. Compound **1** downregulated iNOS and COX-2 expression in LPS-stimulated RAW 264.7 mouse macrophages {#sec3dot5-foods-09-00269}
---------------------------------------------------------------------------------------------------------

The induction of iNOS and COX-2 during inflammation directly contributes to NO synthesis \[[@B31-foods-09-00269]\]. Therefore, we proceeded to verify whether compound **1** (1,5-dimethyl citrate) affects LPS-stimulated iNOS and COX-2. As shown in [Figure 5](#foods-09-00269-f005){ref-type="fig"}, exposure to 1 μg/mL LPS significantly upregulated iNOS and COX-2; however, pretreatment with 50 and 100 μM of compound **1** could reverse the changes induced by LPS. Compound **1** could therefore inhibit the increase in iNOS and COX-2 induced via the NF-κB signaling pathway. On the basis of these results, the suppression in NO production of compound **1** might be associated with downregulating the expression of iNOS and COX-2 by LPS stimulation in RAW 264.7 macrophages.

3.6. Compound **1** downregulated IL-6 and TNF-α production in LPS-stimulated RAW 264.7 mouse macrophages {#sec3dot6-foods-09-00269}
---------------------------------------------------------------------------------------------------------

Elevated expression levels of iNOS and COX-2 followed by an increase in the production of NO have been found to be evoked by TNF-α and IL-6 in RAW 264.7 macrophages \[[@B32-foods-09-00269]\]. Lastly, we proceeded to examine whether compound **1** affected the production of pro-inflammatory cytokines, including IL-6 and TNF-α, in LPS-stimulated RAW 264.7 mouse macrophages. As shown in [Figure 6](#foods-09-00269-f006){ref-type="fig"}, treating RAW 264.7 macrophages with LPS markedly increased IL-6 and TNF-α production, which were ameliorated by 50 and 100 μM of compound **1** in a concentration-dependent manner. These results suggest that compound **1** inhibits IL-6 and TNF-α production, ultimately leading to a reduction in inflammatory response. Altogether, we found that the inhibition of NO production in LPS-activated RAW 264.7 macrophages by compound **1** was mediated by the inhibition of IKKα/β, I-κBα, NF-κB p65, iNOS, and COX-2, as well as the activities of IL-6 and TNF-α ([Figure 7](#foods-09-00269-f007){ref-type="fig"}).

In previous studies, flavonoids as main components of sea buckthorn (*H. rhamnoides*) including isorhamnetin, quercetin, and kaempferol, inhibited LPS-induced NO production in RAW 264.7 cells through the inhibition of expressions of iNOS, COX-2, proteins in the mitogen-activated protein kinase (MAPK) pathway (c-Jun N-terminal kinase and p38), I-κBα, NF-κB p65, and production of pro-inflammatory cytokines (IL-6, IL-1β, and TNF-α) \[[@B33-foods-09-00269]\]. The mechanism of action of flavonoids from sea buckthorn was similar to that of 1,5-dimethyl citrate (**1**) that we identified in this study. However, it has not been known exactly which flavonoid of sea buckthorn exhibits the anti-inflammatory effect. To the best of our knowledge, this study is the first to evaluate the anti-inflammatory activity of citric acid derivative isolated from sea buckthorn on LPS-induced inflammatory response in RAW 264.7 mouse macrophages. The active compound, 1,5-dimethyl citrate (**1**), was a simple derivative of citric acid present in many plants and fruits \[[@B34-foods-09-00269],[@B35-foods-09-00269],[@B36-foods-09-00269],[@B37-foods-09-00269]\]. An anti-inflammatory effect of citric acid derivatives has been reported in previous studies \[[@B34-foods-09-00269],[@B35-foods-09-00269],[@B36-foods-09-00269],[@B37-foods-09-00269]\]. In LPS-treated mice, increased TNF-α in mice brain tissue and iNOS expression in the cytoplasm of hepatocytes were decreased after treatment of citric acid \[[@B34-foods-09-00269]\]. In a recent study, wheat germ extract with citric acid was reported to inhibit secretion of the pro-inflammatory cytokines, TNF-α, IL-6, and IL-12 and the synthesis of COX-2, as well as phosphorylation of NF-κB p65 and p38 kinase in LPS-activated macrophages \[[@B35-foods-09-00269]\]. In addition, calcium citrate showed antioxidant enzyme activities, and inhibited NO production by suppression of the expression of pro-inflammatory mediators (NF-κB, iNOS, and COX-2) and cytokines (TNF-α, IL-1β, and IL-6) in LPS-stimulated RAW 264.7 macrophages \[[@B36-foods-09-00269]\]. Another recent study reported that citric acid displayed anti-inflammatory function via the toll-like receptor (TLR)-mediated activation of NF-κB and interferon regulatory factor-3 signaling pathways, and that citric acid contributed to the maintenance of tight junction proteins via the TLR-mediated p38 and c-Jun N-terminal kinase pathways \[[@B37-foods-09-00269]\]. Interestingly, a new oligosaccharide citric acid derivative isolated from *Vigna angularis* (ohwi *et* ohashi. var. Dainagon) seeds displayed promising anti-influenza A virus activity \[[@B38-foods-09-00269]\]. Additionally, a recent paper reported that citric acid showed protective effect against hepatic ischemia reperfusion injury in Sprague-Dawley rats, which suggests significant therapeutic potential of citric acid in ischemic liver injury \[[@B39-foods-09-00269]\]. Although future in vivo studies should support the anti-inflammatory effects of 1,5-dimethyl citrate (**1**), identified as an active compound in this study, our findings suggest a potential application of 1,5-dimethyl citrate (**1**) for the treatment of inflammatory diseases.

4. Conclusions {#sec4-foods-09-00269}
==============

Herein, we provided experimental evidence of the potential role of 1,5-dimethyl citrate from *H. rhamnoides* fruits in the management and treatment of inflammatory diseases. By performing a phytochemical analysis of the extracts of *H. rhamnoides* fruits using repeated column chromatography, HPLC, and LC/MS, we isolated and identified six compounds (**1--6**), namely, a citric acid derivative (**1**), a phenolic (**2**), two flavonoids (**3** and **4**), and two megastigmane compounds (**5** and **6**). Among them, 1,5-dimethyl citrate (**1**) was demonstrated as effectively preventing LPS-induced NO production and markedly inhibited the expression of IKKα/β, I-κBα, NF-κB p65, iNOS, and COX-2, and the activities of IL-6 and TNF-α. On the basis of our findings, we have provided experimental evidence that the 1,5-dimethyl citrate (**1**) obtained from *H. rhamnoides* fruits could function as an effective agent for the treatment of inflammatory diseases.
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The following are available online at <https://www.mdpi.com/2304-8158/9/3/269/s1>: Figure S1: ECD data of compounds 5 (A) and 6 (B), Figure S2: LC/MS-based analysis (detection wavelength was set as 210 nm) of the ethyl acetate-soluble fraction as well as the chemical structures of compounds 1--4, Figure S3: LC/MS-based analysis (detection wavelength was set as 210 nm) of the CH2Cl2-soluble fraction as well as the chemical structures of compounds 5--6, Figure S4: LC/MS analysis for purity of compounds 1--6.
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![Chemical structures of compounds **1--6**. 1,5-Dimethyl citrate (**1**), 5-methoxysalicylic acid (**2**), syringetin-3-*O*-glucoside (**3**), isorhmanetin-3-*O*-glucoside (**4**), (+)-dehydrovomifoliol (**5**), and (+)-vomifoliol (**6**).](foods-09-00269-g001){#foods-09-00269-f001}

![Effect of compounds **1**--**6** on the viability of RAW 264.7 mouse macrophages. (**A**--**F**) The viability of RAW 264.7 cells incubated with compounds **1--6** for 24 h was measured using an Ez-Cytox cell viability assay (mean ± SD, \* *p* \< 0.05 compared to the lipopolysaccharide (LPS)-treated group). C: control group treated with 0.5% DMSO. 1,5-dimethyl citrate (**1**), 5-methoxysalicylic acid (**2**), syringetin-3-*O*-glucoside (**3**), isorhmanetin-3-*O*-glucoside (**4**), (+)-dehydrovomifoliol (**5**), and (+)-vomifoliol (**6**).](foods-09-00269-g002){#foods-09-00269-f002}

![Effect of compounds **1**--**6** on the LPS-stimulated NO production in RAW 264.7 mouse macrophages. The effect of (**A**--**F**) the compounds and (**G**) *N*^G^-methyl-L-arginine acetate salt (L-NMMA) in LPS-treated RAW 264.7 macrophages was detected using the Griess reagent (mean ± SD, \* *p* \< 0.05 compared to the LPS-treated group). C: control group treated with 0.5% DMSO. 1,5-Dimethyl citrate (**1**), 5-methoxysalicylic acid (**2**), syringetin-3-*O*-glucoside (**3**), isorhmanetin-3-*O*-glucoside (**4**), (+)-dehydrovomifoliol (**5**), and (+)-vomifoliol (**6**).](foods-09-00269-g003){#foods-09-00269-f003}

![Effects of compound **1** on the LPS-induced expression of the IKKα/β (IκB kinase alpha/beta), I-κBα (inhibitor of kappa B alpha), and NF-κB p65 proteins in RAW 264.7 mouse macrophages. (**A**) Representative Western blots of IKKα/β, I-κBα, NF-κB p65, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) protein expression. Quantitative graph of (**B**) p-IKKα/β, (**C**) p-I-κBα, and (**D**) p-p65 (mean ± SD, \* *p* \< 0.05 compared to the LPS-treated group). C: control group treated with 0.5% DMSO. 1,5-dimethyl citrate (**1**).](foods-09-00269-g004){#foods-09-00269-f004}

![Effects of compound **1** on the LPS-induced expression of iNOS and COX-2 in RAW 264.7 mouse macrophages. (**A**) Representative Western blots of iNOS, COX-2, and GAPDH protein expression. Quantitative graph of (**B**) iNOS and (**C**) COX-2 (mean ± SD, \* *p* \< 0.05 compared to the LPS-treated group). C: control group treated with 0.5% DMSO. 1,5-dimethyl citrate (**1**).](foods-09-00269-g005){#foods-09-00269-f005}

![Effects of compound **1** on the LPS-induced cytokine release in RAW 264.7 mouse macrophages. (**A**) Effect of compound **1** on LPS-induced IL-6 production. (**B**) Effects of compound **1** on LPS-induced TNF-α production (mean ± SD, \* *p* \< 0.05 compared to the LPS-treated group). C: control group treated with 0.5% DMSO. 1,5-dimethyl citrate (**1**).](foods-09-00269-g006){#foods-09-00269-f006}

![Schematic model showing the inhibitory effects of compound **1** on lipopolysaccharide-induced inflammatory response in RAW 264.7 mouse macrophages through the inhibition of IKKα/β, I-κBα, NF-κB p65, inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2), and the activities of IL-6 and TNF-α. 1,5-dimethyl citrate (**1**).](foods-09-00269-g007){#foods-09-00269-f007}

[^1]: These authors contributed equally to this work.
